Nitrogen → HCID 67815348, compound
Reaction equation
C([O-])(=O)C.[K+].Br[C:7]1[CH:14]=[CH:13][CH:12]=[CH:11][C:8]=1[C:9]#[N:10].N#N.[CH3:17][O:18][C:19]1[CH:33]=[CH:32][C:22]([CH2:23][O:24][CH2:25][C:26]2[CH:30]=[C:29]([CH3:31])[O:28][N:27]=2)=[CH:21][CH:20]=1>O.[Pd](Cl)Cl.CC(N(C)C)=O>[CH3:17][O:18][C:19]1[CH:20]=[CH:21][C:22]([CH2:23][O:24][CH2:25][C:26]2[C:30]([C:7]3[CH:14]=[CH:13][CH:12]=[CH:11][C:8]=3[C:9]#[N:10])=[C:29]([CH3:31])[O:28][N:27]=2)=[CH:32][CH:33]=1Participants
8
Conditions
- Temperature
- 130 °C
Procedure
To a resealable vial was added potassium acetate (112 mg, 1.143 mmol), palladium(II) chloride (0.507 mg, 2.86 μmol), and 2-bromobenzonitrile (104 mg, 0.572 mmol). The vial was sealed and evacuated and purged with N2 (3×) before addition of DMA (4 mL) and 3-((4-methoxybenzyloxy)methyl)-5-methylisoxazole (200 mg, 0.857 mmol). The vial was heated to 130° C. overnight. The reaction was cooled to room temperature and diluted with water. The aqueous was extracted with EtOAc and the combined organics were washed with brine, dried over Na2SO4, filtered, and concentrated. The crude residue was purified via Biotage (EtOAc/hex) to afford 2-(3-((4-methoxybenzyloxy)methyl)-5-methylisoxazol-4-yl)benzonitrile. LC/MS m/z 335 [M+H]+.
Workup
- customThe vial was sealed
- customevacuated
- temperatureThe reaction was cooled to room temperature
- extractionThe aqueous was extracted with EtOAc
- washthe combined organics were washed with brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customThe crude residue was purified via Biotage (EtOAc/hex)
Sources & evidence
- ORD record
- ord-0e22af52403e43d3badc2b41b90542e0
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08796261B2
Reaction notes
Loading…